medigraphic.com
ISSN 1561-2988 (Print)

2014, Number 2

<< Back Next >>

Rev Cubana Farm 2014; 48 (2)

In vitro antiviral activity of aqueous extract from red seaweed Tricleocarpa fragilis to influenza A virus

Pérez-Riverol A, Piñon RA, Morier DLF, Acosta HB, Valdés IO, del Barrio AG

Language: Spanish
References: 28
Page: 316-328
PDF size: 265.80 Kb.


ABSTRACT

Introduction: influenza viruses are major human pathogens that cause over 500 000 deaths every year. The emergence of viral variants resistant to approved antiviral drugs has prompted the search for new anti-influenza compounds. Alga could be used as a source for the development of new anti-influenza drugs, taking into account the diversity of secondary metabolites previously described in these organisms.
Objective: to evaluate the in vitro antiviral activity of aqueous extract of the red seaweed Tricleocarpa fragilis against influenza A virus.
Methods: the mean citotoxicity (CC50) concentration of the extract was determined by using the MTT reduction assay in MDCK cells. The mean inhibitory concentration (CI50) was estimated by means of viral protein (hemagglutinin) test and a cytopathic effect inhibition test in MDCK cells. The Selective index was calculated from (SI)= CC50/IC50.
Results: T. fragilis was not toxic at the concentrations evaluated in MDCK cells. The aqueous extract inhibited in vitro influenza A(H1N1) and A(H3N2) virus replication with SI values › 11.4 and 106; respectively.
Conclusions: aqueous extract of T. fragilis showed in vitro anti-influenza activity and can be employed as a source for new antiviral drugs. This paper was the first report for the antiviral activity of T. fragilis.


REFERENCES

  1. Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, et al. Surveillance of Resistance to Adamantanes Among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide. J Infect Dis. 2007;196:249-55.

  2. Gubareva LV, Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten R, Xu X, et al. Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008. Antimicrob Agents Chemother. 2008;52(9):3284-92.

  3. El Gamal AA. Biological importance of marine algae. Saudi Pharmaceut J. 2010;18:1-25.

  4. Mayer AMS, Rodríguez AD, Berlinck RGS, Fusetani N. Marine pharmacology in 2007-8: Marine compounds with antibacterial, anticoagulant, antifungal, antiinflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action. Comparative Biochem Physiol. 2011;5:19-22.

  5. Mandal P, Pujol CA, Carlucci MJ, Chattopadhyay K, Damonte EB, Ray B. Antiherpetic activity of a sulfated xylomannan from Scinaia hatei. Phytochemistry. 2008;69:2193-9.

  6. Chattopadhyay K, Mateu CG, Mandal P, Pujol CA, Damonte EB, Ray B. Galactan sulfate of Grateloupia indica: Isolation, structural features and antiviral activity. Phytochemistry. 2007;68:1428-35.

  7. Mori T, O'Keefe BR, Sowder RC, Bringans S, Gardella R, Berg S. Isolation and characterization of griffiths, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem. 2005;280:9345-53.

  8. Talarico LB, Pujol CA, Zibetti RGM, Faría PC, Noseda MD, Duarte ME, et al. The antiviral activity of sulphate polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Res. 2005;66:103-10.

  9. Serkedjieva J. Antiviral Activity of the Red Marine Alga Ceramium rubrum. Phytother Res. 2004;18:480-3.

  10. Chen M, Xie H, Yang L, Liao Z, Yu J. In vitro anti-influenza virus activities of sulfated polysaccharide fractions from Gracilaria lemaneiformis. Virologica Sinica. 2010;25(5):341-51.

  11. Leibbrandt A, Meier C, Konig-Schuster M, Weinmullner R, Kalthoff D, Pflugfelder B, et al. Iota-Carrageenan is a Potent Inhibitor of Influenza A Virus Infection. Plos One. 2010;5(12):e14320.

  12. Wang W, Zhang P, Hao C, Zhang XE, Cui CQ, Guan HS. In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus. Antiviral Res. 2011;92:237-46.

  13. Littler DS, Littler MM. Rhodophyta. In: Littler DS, Littler MM, editor. Caribbean Reef Plants. Washington: Off Shore Graphics; 2000. p. 66.

  14. Shiomi K, Kamiya H, Shimizu Y. Purification and characterization of an agglutinin in the red alga Agardhiella tenera. Biochim Biophyc Acta. 1979;576:118-27.

  15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.

  16. del Barrio G, Parra F. Evaluation of the antiviral activity of an aqueous extract for Phyllantus orbicularis. J Etnopharmacol. 2000;72:317-22.

  17. Al Jabri A, Wigg AMD, Odford JS. Initial in vitro screening of drugs candidates for their potential antiviral activities. In: Mahy BWJ, Kangro HO, editors. Virology Methods Manual. New York: Academic Press; 1996: 60-74.

  18. WHO. Manual for the laboratory and virological surveillance of influenza. Suiza: WHO Press; 2010. p.4.

  19. Ogura F. Hashayi K, Lee JB, Kanekiyo K, Hashayi T. Evaluation of a Edible Blue- Green Algae, Aphanotece sacrum, for Its Inhibitory effects on replication on Herpes Simple Virus Type 2 and Influenza Virus Type A. Bioscien Biotchen Biochem. 2010;74;(8):1687-90.

  20. Vanden Berghe A, Vlietinck AJ, Van Hoof L. Plant products as potential antiviral agents. Bull Pasteur Institute. 1986;84:101-47.

  21. Hayden F, Palese P. Influenza virus. En: Richman DD, Whiley RJ, Hayden FG editors. Clinical Virology. Washington, DC: ASM Press; 2002. p. 891-920.

  22. Ferraris O, Kessler N, Lina B. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. Antiviral Res. 2005;68(1):43-8.

  23. Serkedjieva J, Hay AJ. In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L. Antiviral Res. 1998;37:121-30.

  24. Piñón A, Herrera A, Valdés O, Pérez A, Arencibia A, Savón C, et. al. Adamantane and neuraminidase inhibitor resistance among circulating human influenza A viruses in Cuba during 2006-2010. Int J Antimicrob Agents. 2013;24(1):94-8.

  25. Damonte EB, Matulewicz MC, Cerezo AS. Sulfated seaweed polysaccharides as antiviral agents. Curr Med Chem. 2004(11):2399-419.

  26. Talarico LB, Zibetti RG, Faria PC, Scolaro LA, Duarte ME, Noseda MD, et al. Anti-herpes simplex virus activity of sulfated galactans from the red seaweeds Gymnogongrus griffithsiae and Cryptonemia crenulata. Int J Biol Macromol. 2004;34:63-71.

  27. Hidari KIPJ, Takahashi N, Arihara M, Nagaoka M, Morita K, Suzuki T. Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem Biophys Res Commun. 2008;376:91-5.

  28. Pujol CA, Estevez JM, Carlucci MJ, Ciancia M, Cerezo AS, Damonte EB. Novel galactan hybrids from the red seaweed Gymnogongrus torulosus are potent inhibitors of herpes simplex virus and dengue virus. Antivir Chem Chemother. 2002;13:83-9.




2020     |     www.medigraphic.com